Although there are few reports of studies using immunostaining for FGFR3 according to malignancy, Chang et al. reported that with FGFR3 immunostaining in multiple myeloma, not all the high-grade multiple myeloma showed the high expression level of FGFR3. Here, FGFR3 is linked to plasma cell myeloma.